应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
SBHMY 中国生物制药ADR
休市中 04-24 15:15:21 EDT 延时
资讯
新帖
简况
港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%
智通财经 · 04-16
港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%
智通港股早知道 | 国家数据局拟探索词元交易等新型交易模式 央行上调部分银行境外贷款杠杆率
智通财经 · 04-16
智通港股早知道 | 国家数据局拟探索词元交易等新型交易模式 央行上调部分银行境外贷款杠杆率
港股收盘丨恒指涨0.29% 老铺黄金涨近7%
第一财经 · 04-15
港股收盘丨恒指涨0.29% 老铺黄金涨近7%
中国生物制药:集团自主研发的1类创新药罗伐昔替尼上市获得药监局上市批准
财经网 · 03-02
中国生物制药:集团自主研发的1类创新药罗伐昔替尼上市获得药监局上市批准
中国生物制药慢乙肝1类新药Ⅱ期临床达主要终点,为低病毒血症提供新方案
正大制药订阅号 · 01-27
中国生物制药慢乙肝1类新药Ⅱ期临床达主要终点,为低病毒血症提供新方案
中国生物制药获副总裁兼执行董事谢炘增持100万股 每股作价约6.41港元
新浪网 · 2025-12-25
中国生物制药获副总裁兼执行董事谢炘增持100万股 每股作价约6.41港元
利好密集来袭!创新药概念大爆发
东方财富研究中心 · 2025-10-31
利好密集来袭!创新药概念大爆发
加载更多
公司概况
公司名称:
中国生物制药ADR
所属市场:
PINK LIMITED
上市日期:
--
主营业务:
中国生物制药有限公司是一家主要从事制药业务的投资控股公司。该公司通过三个分部运营。中药现代制剂及西药分部主要从事生产、销售及配销中药现代制剂及西药产品业务。投资分部主要从事长期投资业务。其他分部主要从事相关医疗及医院业务。
发行价格:
--
{"stockData":{"symbol":"SBHMY","market":"US","secType":"STK","nameCN":"中国生物制药ADR","latestPrice":14.2,"timestamp":1777058121789,"preClose":14.2,"halted":0,"volume":40,"delay":15,"changeRate":0,"floatShares":457950931,"shares":910273459,"eps":0.524054,"marketStatus":"休市中","change":0,"latestTime":"04-24 15:15:21 EDT 延时","open":14.2,"high":14.2,"low":14.2,"amount":647.2,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":0.524054,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1777276800000},"marketStatusCode":7,"adr":0,"adrRate":20,"exchange":"PINK LIMITED","adjPreClose":14.2,"volumeRatio":0.9132395071063732},"requestUrl":"/m/hq/s/SBHMY","defaultTab":"news","newsList":[{"id":"2627254292","title":"港股公告掘金 | 宁德时代一季度归母净利润207.38亿元 同比增长48.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627254292","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627254292?lang=zh_cn&edition=full","pubTime":"2026-04-16 09:01","pubTimestamp":1776301266,"startTime":"0","endTime":"0","summary":"【重大事项】宁德时代(03750)拟投资 300 亿元设立全资子公司 打造新能源矿产平台美格智能(03268)拟投资3亿元于AI研发及先进制造产业项目并签署投资协议力勤资源(02245):印尼镍矿政策变动不影响正常经营 与合作伙伴保持良好合作关系确保Obi项目稳定运行中远海能(01138)拟10.18亿元建造两艘巴拿马型原油轮荣昌生物(09995):收到艾伯维就RC148独家授权许可协议支付的6.","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":"05d74946e1a2924d42dd26ed36b9a988","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429147.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00670","LU2125910849.SGD","LU1105468828.SGD","LU2152927971.USD","LU0516422366.SGD","IE00B5MMRT66.SGD","LU2125910500.SGD","SG9999001903.USD","LU0164872284.USD","LU2506952410.USD","SGXZ49509284.SGD","LU1102505929.USD","EVS.SI","300750","LU1039395188.USD","LU0456846285.SGD","02298","LU2097828631.EUR","BK1575","SG9999001846.SGD","LU0540923850.HKD","LU1720050803.USD","LU0107464264.USD","IE00B8L5B284.USD","LU0979878070.USD","BK1166","LU0326948709.USD","SBHMY","LU0359201612.USD","HXXD.SI","LU1969619763.USD","IE00B8HQ1Z84.USD","IE00BD6J9T35.USD","LU0456827905.SGD","LU1064131003.USD","08279","LU0650527681.SGD","02556","IE0034224299.USD","LU1051768304.USD","LU0359202008.SGD","LU0823039010.USD","LU0188438112.USD","LU2348773727.SGD","LU1048596156.SGD","LU0348816934.USD","LU0328353924.USD","LU0143863784.USD","02465","LU0611395673.USD","LU0348805143.USD","LU0516423091.SGD","LU0348814723.USD","LU0594300179.USD","LU1323998911.USD","LU0259732245.USD","LU2360107325.USD","600026","LU0823397103.USD","LU2294711713.HKD","02038","LU2580892789.USD","002881","00300","CCOZY","LU0672654166.SGD","LU1146622755.USD","603906","LU0039217434.USD","LU2226246903.HKD","LU0251143458.SGD","LU0261950470.USD","LU0607220059.USD","BK1116","BK0224","LU0307460666.USD","LU0047713382.USD","LU2476274308.USD","BK4526","LU0011963245.USD","601898","02245","LU0128522157.USD","LU3063872942.SGD","FXCNY","LU0823437842.USD","LU0823038988.USD","LU0051755006.USD","LU1580142542.USD","LU2298322129.HKD","LU0348827113.USD","LU0823040885.USD","LU1978683503.SGD","LU0117841782.USD","09995","LU0823426480.USD","LU2097828474.EUR","LU0505663152.USD","06613","LU2148510915.USD","LU0320764755.SGD","LU1769817179.HKD","LU0700851271.USD","LU0499858438.USD","LU2477742899.HKD","LU0029875118.USD","LU0048580855.USD","LU0132412106.USD","LU2495084118.USD","LU0345775950.USD","LU0594300419.USD","LU1808992512.USD","LU0370786039.SGD","LU0254981946.USD","LU0106259558.USD","LU0169518387.USD","LU1770036033.HKD","LU0052750758.USD","LU0463099449.HKD","LU0124384867.USD","LU0149534421.HKD","LU1934453819.USD","IE00B3M56506.USD","LU0572944931.SGD","02186","BK1615","01093","BK1589","LU0210526637.USD","LU0405327494.USD","SG9999001689.USD","LU1956131251.USD","LU2045819591.USD","LU0049853897.USD","LU0348825331.USD","LU2399975544.HKD","LU1781817850.SGD","SG9999002463.SGD","LU1051769294.HKD","SG9999002828.SGD","01177","SG9999001093.SGD","LU1831875114.USD","BK1506","LU0235996351.USD","BK1535","LU0675040207.SGD","03908","BK1502","BK1523","LU0302445910.USD","LU0724618433.USD","LU2249611893.SGD","LU0634319403.HKD","LU1868838027.USD","LU0192582467.USD","BK1610","LU0348735423.USD","LU0708995583.HKD","LU1813983027.USD","LU2097828805.USD","LU1242518857.USD","LU1794554557.SGD","000333","BK1618","LU1064130708.USD","300433","01138","LU1997244956.HKD","LU0417516902.SGD","LU0165289439.USD","LU0499858602.USD","IE0003795394.USD","LU1868837565.USD","LU0823414551.USD","LU0106252389.USD","LU0149721374.USD","LU0501845795.SGD","LU1997245177.USD","LU2778985437.USD","LU1008478684.HKD","LU2506952337.HKD","LU1251922891.USD","LU1880383440.USD","LU0140636845.USD","LU2328871848.SGD","LU0405327148.USD","SG9999000459.SGD","LU0048575426.USD","LU1303224171.USD","LU2506951792.HKD","LU0509642566.USD","LU0043850808.USD","LU0455707207.USD","LU2298064838.USD","LU1961090484.USD","601995","LU1861214812.USD","LU0067412154.USD","LU2357125470.USD","LU1979443071.USD","SGXZ81163826.USD","LU0502904849.HKD","LU0823413587.USD","01898","LU0880133367.SGD","MIUmain","IE00BPRC5H50.USD","LU2275660780.HKD","LU2087589342.USD","LU0797268264.HKD","LU0469268626.HKD","601111","IE00B543WZ88.USD","LU0211977185.USD","LU1655091616.SGD","LU0651946864.USD","LU2153592121.USD","BK1521","LU0228659784.USD","LU0531971595.HKD","LU0072913022.USD","LU0543330483.HKD","LU2242644610.SGD","LU0651947912.USD","LU0828238088.HKD","LU0244354667.USD","LU1820825898.SGD","LU0828237940.HKD","LU0871576103.HKD","LU1960683339.HKD","LU1102505762.USD","LU0417516738.SGD","HK0000286598.CNH","LU2289578879.USD","LU2506952253.HKD","LU1880383366.USD","LU0269904917.USD","LU1770034418.SGD","LU1993786604.SGD","LU0516423174.USD","LU0588546209.SGD","LU0449515922.USD","LU1255011170.USD","SG9999014674.SGD","LU0516422952.EUR","LU0072462343.USD","LU1721428347.USD","LU0449509016.USD","LU0441854154.USD","BK1193","LU2449936058.SGD","BK4141","SG9999003461.SGD","LU1981816686.USD","LU1152091754.HKD","LU1242518931.SGD","LU0345776255.USD","LU0605514214.HKD","LU2476274720.SGD","IE00B29SXG58.USD","LU1188198961.HKD","LU0181495838.USD","LU1481107354.HKD","LU2097828714.EUR","HK0000181112.HKD","LU0823426308.USD","BK1607","LU1048588211.SGD","BK4588","002352","LU2097828557.USD","LU2294711473.HKD","LU0312595415.SGD","LU0823413660.USD","LU2580892862.HKD","LU1282648689.USD","600115","XIACY","81810","LU1939255532.USD","LU0164880469.USD","BK1149","LU0314109678.HKD","LU0214875030.USD","LU0561508036.HKD","LU0593848301.USD","LU0516422440.USD","LU0918141887.USD","LU0828237510.HKD","LU2257852520.SGD","03268","LU0320764599.SGD","LU1807302812.USD","LU0531970944.HKD","LU1719994722.HKD","688331","LU0164865239.USD","LU1023057109.AUD","SG9999000327.SGD","LU0048388663.USD","LU0823414478.USD","HK0000165453.HKD","IE0032431581.USD","LU2153591404.USD","LU0231483743.USD","IE00BZ199S13.USD","LU1769817096.USD","LU0823041008.USD","LU2039709279.SGD","BK4585","LU1997245094.SGD","LU1328277881.USD","LU0106959298.USD","06656","LU2424517915.HKD","LU2348774022.SGD","06936","HK0000181138.USD","LU1515016050.SGD","00753","IE0003851619.USD","LU0084288322.USD","LU0143863198.USD","LU0054450605.USD","LU0918141705.HKD","LU0359201885.HKD","LU2238339852.HKD","LU0823397285.USD","01810","BK4519","LU0327786744.USD","LU1152091168.USD","LU1861219969.SGD","03750","LU0326950275.SGD","LU0821914370.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627256069","title":"智通港股早知道 | 国家数据局拟探索词元交易等新型交易模式 央行上调部分银行境外贷款杠杆率","url":"https://stock-news.laohu8.com/highlight/detail?id=2627256069","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627256069?lang=zh_cn&edition=full","pubTime":"2026-04-16 07:41","pubTimestamp":1776296486,"startTime":"0","endTime":"0","summary":"探索词元交易等新型交易模式,构建以词元为基础,可量化、可定价的数据集价值体系。将进出口银行的境外贷款杠杆率由3上调至3.5。截至收盘,暗盘交易显示报价578港元,较招股价324.2港元上涨78.29%,每手100股,不计手续费,每手赚25380港元。归属于上市公司股东的净利润为207","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1429117.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1116","LU1152091754.HKD","LU1960683339.HKD","LU1023057109.AUD","601995","BK1564","LU1152091168.USD","LU1807302812.USD","BK4588","01177","SBHMY","03750","LU2328871848.SGD","SG9999002828.SGD","LU0359202008.SGD","LU1008478684.HKD","BK1147","BK1610","LU0067412154.USD","BK1190","BK1161","300750","BK4585","08279","02245","BK1574","LU1993786604.SGD","688331","LU0359201612.USD","BK1501","LU0880133367.SGD","BK1516","BK1583","06656","LU1969619763.USD","09995","LU0359201885.HKD","03908"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627404427","title":"港股收盘丨恒指涨0.29% 老铺黄金涨近7%","url":"https://stock-news.laohu8.com/highlight/detail?id=2627404427","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2627404427?lang=zh_cn&edition=full","pubTime":"2026-04-15 16:12","pubTimestamp":1776240751,"startTime":"0","endTime":"0","summary":"恒生指数收涨0.29%,恒生科技指数涨1.23%。老铺黄金涨近7%,信达生物、中国生物制药涨逾5%,京东集团涨逾4%,阿里巴巴、携程集团、百度集团涨逾3%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202604153705909775.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604153705909775.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["09618","BK4588","MCHmain","01177","BABA","02833","SGXZ90724238.SGD","BK1544","513600","JD","TCOM","01801","HHImain","SG9999001051.SGD","09988","BK1227","MHImain","06181","BK4585","HSTECH","09961","SBHMY","HSI"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616332509","title":"中国生物制药:集团自主研发的1类创新药罗伐昔替尼上市获得药监局上市批准","url":"https://stock-news.laohu8.com/highlight/detail?id=2616332509","media":"财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616332509?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:26","pubTimestamp":1772443607,"startTime":"0","endTime":"0","summary":"近日,中国生物制药发布公告称,集团自主研发的国家1类创新药罗伐昔替尼片已获得中国国家药品监督管理局的上市批准,适用于中危-2或高危的原发性骨髓纤维化、真性红细胞增多症后骨髓纤维化或原发性血小板增多症后骨髓纤维化成年患者的一线治疗。在一项多中心、随机、双盲、双模拟、阳性药物平行对照的II期临床研究中,罗伐昔替尼对比羟基尿在治疗中危-2、高危骨髓纤维化患者中展示出优异的疗效和良好的安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302173018a731073c&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20260302173018a731073c&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007","PMF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606016224","title":"中国生物制药慢乙肝1类新药Ⅱ期临床达主要终点,为低病毒血症提供新方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2606016224","media":"正大制药订阅号","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606016224?lang=zh_cn&edition=full","pubTime":"2026-01-27 07:01","pubTimestamp":1769468467,"startTime":"0","endTime":"0","summary":"近日,中国生物制药核心企业正大天晴宣布,其针对慢性乙型肝炎病毒感染的口服1类新药——核心蛋白变构调节剂TQA3605在Ⅱ期临床研究中达到主要研究终点。临床现有抗病毒药物如核苷(酸)类药物可以有效抑制HBV复制,但部分患者仍存在应答不佳及低病毒血症,危害不容忽视。此外,低病毒血症患者的疾病进展风险更高,肝细胞癌发生率是病毒完全抑制者的2-4倍甚至更高。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012707062897a37ab8&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026012707062897a37ab8&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","01177","IE00BZ08YR35.GBP","BK1521","HK0000165453.HKD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1515","BK1589","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2594235936","title":"中国生物制药获副总裁兼执行董事谢炘增持100万股 每股作价约6.41港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2594235936","media":"新浪网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2594235936?lang=zh_cn&edition=full","pubTime":"2025-12-25 08:18","pubTimestamp":1766621894,"startTime":"0","endTime":"0","summary":"热点栏目自选股数据中心行情中心资金流向模拟交易客户端香港联交所最新资料显示,12月24日,副总裁兼执行董事谢炘增持中国生物制药100万股,每股作价6.4068港元,总金额为640.68万港元。增持后最新持股数目约为3.61亿股,最新持股比例为1.92%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225102536a47593c4&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251225102536a47593c4&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["SBHMY","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2579462065","title":"利好密集来袭!创新药概念大爆发","url":"https://stock-news.laohu8.com/highlight/detail?id=2579462065","media":"东方财富研究中心","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2579462065?lang=zh_cn&edition=full","pubTime":"2025-10-31 17:54","pubTimestamp":1761904444,"startTime":"0","endTime":"0","summary":"据证券时报报道,今年国家医保谈判在延续医保目录常规调整机制的基础上,首次正式引入“商保创新药目录”机制。此外,年内国产创新药“出海”进程明显提速。根据医药魔方NextPharma数据库,截至10月21日,中国创新药今年对外许可共发生115起,金额总计达到1012.4亿美元,远超2024年全年的519亿美元。国信证券指出,中国创新药产业已经体现出长期向好的发展趋势,并在近年集中体现在BD交易的爆发式增长。配置上,看好创新药长期逻辑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20251031180526a47fc459&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["02552","09995","06990","SBHMY","01952","03759","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.sinobiopharm.com","stockEarnings":[{"period":"1week","weight":0.1201},{"period":"1month","weight":-0.0113},{"period":"3month","weight":0.2931},{"period":"6month","weight":0.5235},{"period":"1year","weight":0.6487},{"period":"ytd","weight":1.1867}],"description":"中国生物制药有限公司是一家主要从事制药业务的投资控股公司。该公司通过三个分部运营。中药现代制剂及西药分部主要从事生产、销售及配销中药现代制剂及西药产品业务。投资分部主要从事长期投资业务。其他分部主要从事相关医疗及医院业务。","exchange":"PINK LIMITED","name":"中国生物制药ADR","nameEN":"Sino Biopharmaceutical Ltd."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"中国生物制药ADR(SBHMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供中国生物制药ADR(SBHMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"中国生物制药ADR,SBHMY,中国生物制药ADR股票,中国生物制药ADR股票老虎,中国生物制药ADR股票老虎国际,中国生物制药ADR行情,中国生物制药ADR股票行情,中国生物制药ADR股价,中国生物制药ADR股市,中国生物制药ADR股票价格,中国生物制药ADR股票交易,中国生物制药ADR股票购买,中国生物制药ADR股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"中国生物制药ADR(SBHMY)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供中国生物制药ADR(SBHMY)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}